CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid - In Capital	Accumulated Deficit	Cumulative Translation Adjustment
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021		40,865,336
Stockholders' equity, beginning balance at Dec. 31, 2021	$ 212,423	$ 4	$ 281,815	$ (69,396)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	362		362
Issuance of shares, net of issuance costs (in shares)		415,000
Issuance of shares, net of issuance costs	3,791	$ 0	3,791
Restricted shares award issuance, net of withholdings (in shares)		82,601
Stock-based compensation expense	(65)		(65)
Proceeds from stock options exercised	2		2
Proceeds from stock options exercised (in shares)		334
Foreign currency translation adjustment	(32)				(32)
Net loss	(429)			(429)
Stockholders' equity ending balance (in shares) at Mar. 31, 2022		41,363,271
Stockholders equity, ending balance at Mar. 31, 2022	216,052	$ 4	285,905	(69,825)	(32)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022		46,252,779
Stockholders' equity, beginning balance at Dec. 31, 2022	(47,047)	$ 5	293,769	(340,464)	(357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	481		481
Issuance of shares, net of issuance costs (in shares)		12,119,264
Issuance of shares, net of issuance costs	$ 8,096	$ 1	8,095
Restricted shares award issuance, net of withholdings (in shares)		92,751
Issuance of shares for amendment fee associated with debt modification (Note 9), net of issuance costs (in shares)	1,333,333
Issuance of shares for amendment fee associated with debt modification (Note 9), net of issuance costs	$ 1,000		1,000
Foreign currency translation adjustment	17				17
Net loss	(8,171)			(8,171)
Stockholders' equity ending balance (in shares) at Mar. 31, 2023		59,798,127
Stockholders equity, ending balance at Mar. 31, 2023	$ (45,624)	$ 6	$ 303,345	$ (348,635)	$ (340)